To view the fulltext, please log in
To view the pdf, please log in
- FullText & PDF
- Unlimited re-access via MyKarger (new!)
- Unrestricted printing, no saving restrictions for personal use
- Reduced rates with a PPV account
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restriction apply
Rental: USD 8.50
Cloud: USD 20.00
- Automatic perpetual access to all articles of the subscribed year(s)
- Unlimited re-access via Subscriber Login or MyKarger
- Unrestricted printing, no saving restrictions for personal use
Article / Publication Details
Background: The exposure of human skin to leaves and branches of litre (Lithraea caustica), a Chilean endemic tree, induces a severe contact dermatitis characterized by swelling and pruritus in susceptible individuals. The allergenic priniciple of litre is 3–pentadecyl (10–enyl) catechol (litreol), which is structurally similar to the allergens isolated from poison oak and poison ivy. All of them belong to a family of compounds named urushiols. As a proelectrophilic allergen, litreol must be intracellularly activated before modifying proteins of individuals exposed to it. As a result, self–peptides derived from litreol–modified intracellular proteins would be presented in the context of class I MHC molecules. We hypothesized that CD8+ T lymphocytes would play a major role during the effector phase of the immune response induced by those modified peptides. In order to test this hypothesis, we investigated the cellular immune response to litreol in Balb/cJ mice. The role of the different lymphocyte subpopulations in this response was assessed by immunodepleting mice of CD4+ or CD8+ T lymphocytes using specific monoclonal antibodies (mAbs). We report the observation that the contact dermatitis induced by litreol has two components: a primary response which does not require TCRαβ+ T cells, and a secondary response mediated mainly by CD8+ T cells and regulated by CD4+ T cells. Our results show that CD8+ lymphocytes play a central role as effectors of the secondary response to litreol. Furthermore, our data suggest that two functionally different CD4+ T subpopulations serve as regulators of the CD8+ T cell function: a CD4+ T helper population sensitive to a low dose of the depleting mAb, and CD4+ T suppressor population which is eliminated only with a high dose of depleting mAb.
Article / Publication Details
Copyright / Drug Dosage
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
- Benezra C: Molecular recognition in allergic contact dermatitis to natural products. Pure Apple Chem 1990;62:1251–1258
- Meltzer M, Nacy C: Delayed–type hypersensitivity and the induction of activated, cytotoxic macrophages; in Paul WE (ed): Fundamental Immunology. New York, Raven Press, 1989, p 765.
- Kalish R: Recent developments in the pathogenesis of allergic contact dermatitis. Arch Dermatol 1991;127:1558–1563.
- Harlow W: Poison ivy and Poison sumac. New York State College of Forestry at Syracuse 1990, vol. 22, p 4.
- Dawson CR: Final Report on the Chemistry of poison ivy (Contract Nr PH–43–64–76), US Department of Commerce, National Technical Information Service, Springfield, 1973.
- Gambaro V, Chamy M, von Brand E, Garbarino J: 3–(pentadec–10–enyl)–catechol, a new allergenic compound from Lithreae caustica (Anacardiaceae). Planta Med 1986;15:20–22.
- Baer H, Watkins R, Bowser R: Delayed contact sensitivity to catechols and resorcinols. The relationship of structure and immunization procedure to sensitizing capacity. Inmunochemistry 1966;3:479–485.
- Byers V, Castagnoli N, Epstein W: In vitro studies of poison oak immunity. II. Effect of urushiol analogues on the human in vitro response. J Clin Invest 1979;64:1449–1456.
- Johnson R, Baer H, Kirkpatrick C, Dawson C, Khurana R: Comparison of the contact allergenicity of the four pentadecylcatechols derived from poison ivy urushiol in human subjects. J Allergy Clin Immunol 1972;49:27–35.
- Kalergis A, López CB, Becker MI, Díaz MI, Sein J, Garbarino JA, De Ioannes AE: Modulation of fatty acid oxidation alters contact hypersensitivity to urushiols: Role of aliphatic chain beta–oxidation in processing and activation of urushiols. J Invest Dermatol 1997;108: 57–61.
- Cher D, Mosmann T: Two types of murine helper T cell clone. II. Delayed–type hypersensitivity is mediated by TH1 clones. J Immunol 1987;138:3688–3694.
- Liew F: Regulation of delayed–type hypersensitivity to pathogens and alloantigens. Immunol Today 1982;3:18–23. .
- Waldorf H, Walsh LS, Murphy G: Early cellular events in evolving cutaneous delayed hypersensitivity in humans. Am J Pathol 1991; 138:477–486.
- Gocinski B, Tigelaar R: Roles of CD4+ and CD8+ T cells in murine contact sensitivity revealed by in vivo monoclonal antibody depletion. J Immunol 1990;144:4121–4128.
- Bour H, Peyron E, Gaucherand M, Garrigue J, Desvignes C, Kaiserlian D, Revillard J, Nicolas J: Major histocompatibility complex class I–Restricted CD8+ T cells and class II–restricted CD4+ T cells, respectively, mediate and regulate contact sensitivity to dinitrofluorobenzene. Eur J Immunol 1995;25:3006– 3010.
- Kalish R, Wood J, LaPorte A: Processing of urushiol (poison ivy) hapten by both endogenous and exogenous pathways for presentation to T cells in vitro. J Clin Invest 1994;93: 2039–2047.
- Laemmli EK: Cleavage of structural proteins the assembly of the head of bacteriophage T4. Nature 1970;227:680–685.
- Harlow E, Lane D: Antibodies: Laboratory Manual, New York, Cold Spring Harbor Laboratory, 1988, p 392.
- Jennings S, Bonneau R, Smith P, Wolcott R, Chervenak R: CD4–positive T lymphocytes are required for the generation of the primary but not the secondary CD8–positive cytolytic T lymphocyte response to herpes simplex virus in C57BL/6 mice. Cell Immunol 1991;133: 234–252.
- Cobbold SP, Jayasuriya A, Nash A, Prospero TD, Waldmann H: Therapy with monoclonal antibodies by elimination of T–cell subsets in vivo. Nature 1984;312:548–551.
- Rice J, Bucy R: Differences in the degree of depletion, rate of recovery, and the preferential elimination of naive CD4+ T cells by anti–CD4 monoclonal antibody (GK1.5) in young and aged mice. J Immunol 1995;154:6644–6654.
- Bosma G, Custer R, Bosma M: A severe combined immunodeficiency mutation in the mouse. Nature 1983;301:527–530.
- Bosma M, Carroll A: The SCID mouse mutant: Definition, characterization, and potential uses. Annu Rev Immunol 1991;9:323–350.
- Dorshkind K, Pollack S, Bosma M, Phillips R: Natural killer (NK) cells are present in mice with severe combined immunodeficiency (scid). J Immunol 1985;134:3798–3810.
- Roelandt L, Todaro A, Thome JP, Kremers P: Effects of PCBs (Aroclor 1254) on cytochrome–P450 expression and monooxygenase activities incultured foetal rat hepatocytes. Toxicology 1995;98:95–103.
- Pairon JC, Trabelsi N, Buard A, Fleury–Feith J, Bacheler CM, Poron F, Beaune P, Brochard P, Laurent P: Cell localization and regulation of expression of cytochrome P450 1A1 and 2B1 in rat lung after induction with 3–methylcholanthrene using mRNA hybridization and immunohistochemistry, Am J Resp Cell Molec Biol 1994;11:386–396.
- Burke MD, Thompson S, Weaver RJ, Walf CR, Mayer RT: Cytochrome P450 specificities of alkoxyresorufin O–dealkylation in human and rat liver. Biochem Pharmacol 1994;48:923 –936.
- Jugert FK, Agarwal R, Kuhn A, Bickers DR, Merk HF, Mukhtar H: Multiple cytochrome P450 isozymes in murine skin: induction of P450 1A, 2B, 2E, and 3A by dexamethasone. J Invest Dermatol 1994;102:970–975.
- Allison J, Havran W: The immunobiology of T cells with invariant gamma delta antigen receptors. Annu Rev Immunol 1991;9:679–705.
- Kaminski M, Bergstresser P, Takashima A: In vivo activation of mouse dendritic epidermal T cells in sites of contact dermatitis. Eur J Immunol 1993;23:1715–1718.
- Askenase PW, Szczepanik M, Ptak M, Paliwal V, Ptak W: Gamma delta T cells in normal spleen assist immunized alpha beta T cells in the adoptive cell transfer of contact sensitivity. Effect of Bordetella pertussis cyclophosphamide, and antibodies to determinants on suppressor cells. J Immunol 1995;154:3644– 3653.
- Huber H, Descossy P, van Brandwijk R, Knop J: Activation of murine epidermal TCR–gamma delta+ T cells by keratinocytes treated with contact sensitizers. J Immunol 1995;155: 2888–2894.
- Matsuda H, Ushio H, Geba GP, Askenase PW: Human platelets can initiate T–cell–dependent contact sensitivity through local serotonin release mediated by IgE antibodies. J Immunol 1997;158:2891–2894.
- Tsuji RF, Geba GP, Wang Y, Kawamoto K, Askenase PW: Required early complement activation of local C5–dependent chemotactic activity, and late T cell interferon gamma: A possible initiating role of B cells. J Exp Med 1997; 186:1015–1026.
- Xu H, Dilulio N, Fairchild R: T cell populations primed by hapten sensitization in contact sensitivity are distinguished by polarized patterns of cytokine production: Interferon gamma–producing (Tc1) effector CD8+ T cells and interleukin (II) 4/II–10–producing (Th2) negative regulatory CD4+ T cells. J Exp Med 1996; 183:1001–1012.
- Dilulio N, Xu H, Fairchild R: Diversion of CD4+ T cell development from regulatory T helper to effector T helper cells alters the contact hypersensitivity response Eur J Immunol 1996;26:2606–2612.
- Ushio H, Tsuji RF, Szczepanik M, Kawamoto K, Matsuda H, Askenase PW: IL–12 reverses established antigen–specific tolerance of contact sensitivity by affecting costimulatory molecules B71 (CD80) and B7–2 (CD86). J Immunol 1998;160:2080–2088.
- Gelber C, Gemmell L, McAteer D, Homola M, Swain P, Liu A Wilson J, Gefter M: Down–regulation of poison ivy/oak–induced contact sensitivity by treatment with a class II MHC binding peptide: Hapten conjugate. J Immunol 1997;158:2425–2434.
- van der Kwast TH, Benner R: The involvement of T1 and T2 lymphocytes in primary and secondary delayed type hypersensitivity responsiveness. Ann Immunol 1977;128:1019– 1024.
- Hahn H, Kaufmann SH, Falkenberg F, Chahinin M, Horn W: Peritoneal exudate T lymphocytes with specificity to sheep red blood cells. II. Inflammatory helper T cells and effector T cells in mice with delayed–type hypersensitivity and in suppressed mice. Immunology 1979;38:51–55.
- Tamura S, Kikuta K, Kobayashi T, Sato Y, Sato H: Studies on primed precursors of effector T cells involved in delayed–type hypersensitivity to shepp red blood cells in mice. Cell Immunol 1987;108:120–131.